HOUSTON – (Nov. 9, 2022) – Life science innovators, academics and investors – including those specializing in health tech, medical devices and therapeutics – convened at Rice University this week to discuss Houston’s role in the future of health care and give awards to top early-stage life science companies.
The 11th annual Texas Life Science Forum, co-hosted on Nov. 8 by BioHouston and the Rice Alliance for Technology and Entrepreneurship in partnership with the Texas Medical Center (TMC) and JLABS @ TMC, is the premier life science and health tech event in Texas. Attendees heard pitches from innovative, early-stage life science companies and attended panels and keynote presentations from more than 40 speakers.
The 48 presenting companies — about half of them based in Houston — pitched to more than 500 venture capitalists, corporate innovation groups, angel networks, industry leaders, academics and service providers. These companies have already raised a combined total of more than $252 million in funding.
